Literature DB >> 17257674

Coordination of upregulated XBP-1 and downregulated c-myc during myeloma cell differentiation induced by 2-methoxyestradiol.

Xia Zhou1, Hua Jiang, Jian Hou.   

Abstract

Our previous studies showed that 2-methoxyestradiol (2ME2) at low concentrations (0.1-0.5 micromol/l) could induce differentiation of myeloma cells, and transcription factors Blimp-1 and XBP-1 repressed by Pax-5 were both upregulated. The present study was aimed at elucidating the molecular mechanism underlying 2ME2-induced myeloma cell differentiation. We demonstrated that cell differentiation required not only Blimp-1 to upregulate XBP-1expression but also Blimp-1 to inhibit c-myc activity. These two signal transduction pathways worked dependently of each other and synergistically to promote the differentiation process of myeloma cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17257674     DOI: 10.1016/j.leukres.2006.11.023

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  3 in total

1.  Unfolded protein response inducers tunicamycin and dithiothreitol promote myeloma cell differentiation mediated by XBP-1.

Authors:  Hua Jiang; Jianfeng Zou; Hui Zhang; Weijun Fu; Tianmei Zeng; Hejing Huang; Fan Zhou; Jian Hou
Journal:  Clin Exp Med       Date:  2013-12-20       Impact factor: 3.984

2.  Activation of the endoplasmic reticulum stress-associated transcription factor x box-binding protein-1 occurs in a subset of normal germinal-center B cells and in aggressive B-cell lymphomas with prognostic implications.

Authors:  Olga Balague; Ana Mozos; Daniel Martinez; Luis Hernandez; Lluis Colomo; Jose Luis Mate; Julie Teruya-Feldstein; Oscar Lin; Elias Campo; Armando Lopez-Guillermo; Antonio Martinez
Journal:  Am J Pathol       Date:  2009-04-23       Impact factor: 4.307

3.  Involvement of DNA methyltransferase 1 (DNMT1) and multidrug resistance-associated proteins in 2-methoxyestradiol-induced cytotoxicity in EC109/Taxol cells.

Authors:  Qingqing Yang; Xiaojing Guo; Yue Xu; Chang Duan; Haofan Wang; Quanling Feng; Nan Zhang
Journal:  Transl Cancer Res       Date:  2021-01       Impact factor: 1.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.